Medicare Enrolled
Dr. Rakesh Rohatgi, M.D.
Medical Oncology · The Villages, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rohatgi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rohatgi? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rohatgi
Dr. Rakesh Rohatgi is a medical oncology in The Villages, FL, with 20 years in practice. Based on federal Medicare data, Dr. Rohatgi performed 405,674 Medicare services across 6,639 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rohatgi received a total of $22,243 from 91 pharmaceutical and/or device companies across 982 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rohatgi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 3% volume in FL$ $22,243 industry payments
Medicare Practice Summary
Medicare Utilization ↗405,674
Medicare services
Top 3% in FL for medical oncology
6,639
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~20,284 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 129,030 | $0 | $4 |
| Iron infusion (Injectafer) | 105,750 | $1 | $3 |
| Filgrastim injection (Zarxio) for white blood cells | 45,600 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 39,180 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 19,220 | $6 | $23 |
| Pembrolizumab injection (Keytruda) | 18,000 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 13,520 | $1 | $5 |
| Dexamethasone injection (steroid) | 4,600 | $0 | $3 |
| Injection, eflapegrastim-xnst, 0.1 mg | 4,356 | $26 | $116 |
| Blood draw (venipuncture) | 4,038 | $8 | $9 |
| Complete blood count (CBC) with differential | 3,946 | $8 | $29 |
| Iron infusion (Monoferric) | 3,200 | $16 | $57 |
| Anti-nausea injection (ondansetron/Zofran) | 2,536 | $0 | $9 |
| Office visit, established patient (30-39 min) | 2,401 | $93 | $339 |
| Drug injection, under skin or into muscle | 1,969 | $10 | $69 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,610 | $1 | $28 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 717 | $1 | $6 |
| Administration of chemotherapy into vein, 1 hour or less | 669 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 626 | $22 | $84 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 611 | $47 | $189 |
| Office visit, established patient (20-29 min) | 480 | $66 | $239 |
| Injection, carboplatin, 50 mg | 450 | $2 | $41 |
| Injection of additional new drug or substance into vein | 280 | $11 | $61 |
| Red blood count, automated test | 272 | $4 | $10 |
| Administration of additional new drug or substance into vein, 1 hour or less | 219 | $49 | $178 |
| New patient office visit (45-59 min) | 199 | $124 | $452 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 185 | $17 | $59 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 181 | $54 | $206 |
| Infusion into a vein for hydration, each additional hour | 172 | $10 | $42 |
| Prothrombin time test (blood clotting) | 169 | $4 | $15 |
| Initial hospital admission, moderate complexity | 153 | $99 | $377 |
| Injection, diphenhydramine hcl, up to 50 mg | 143 | $1 | $3 |
| Injection of drug or substance into vein | 142 | $27 | $156 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 125 | $3 | $11 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 110 | $1 | $7 |
| Hospital follow-up visit, moderate complexity | 107 | $62 | $197 |
| Infusion, normal saline solution , 1000 cc | 106 | $2 | $7 |
| Injection, magnesium sulfate, per 500 mg | 104 | $1 | $2 |
| Administration of chemotherapy into vein, each additional hour | 101 | $21 | $79 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 67 | $25 | $89 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 66 | $134 | $562 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 62 | $15 | $56 |
| Infusion into a vein for hydration, 31-60 minutes | 39 | $25 | $156 |
| Automated urinalysis | 38 | $2 | $8 |
| New patient office visit (30-44 min) | 32 | $67 | $298 |
| Initial hospital admission, high complexity | 32 | $137 | $556 |
| Office visit, established patient, complex (40-54 min) | 29 | $140 | $474 |
| Drawing of blood for a medical problem | 18 | $69 | $277 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 14 | $128 | $467 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
59.1% high complexity
37.9% medium
3.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,243
Total received (2018-2024)
Avg $3,178/year across 7 years
Top 23% in FL for medical oncology
91
Companies
982
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,681 (79.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,869 (8.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,385 (6.2%)
Other
Charitable contributions, space rental, and other categories
$1,308 (5.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,982
2023$3,415
2022$3,512
2021$1,550
2020$836
2019$5,023
2018$2,925
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,624
Dova Pharmaceuticals
$1,869
Janssen Biotech, Inc.
$1,390
E.R. Squibb & Sons, L.L.C.
$1,198
AstraZeneca Pharmaceuticals LP
$997
PFIZER INC.
$994
Incyte Corporation
$856
Astellas Pharma US Inc
$838
GENZYME CORPORATION
$753
Celgene Corporation
$751
Daiichi Sankyo Inc.
$711
Seagen Inc.
$647
Genentech USA, Inc.
$616
Merck Sharp & Dohme LLC
$570
Amgen Inc.
$569
Eisai Inc.
$389
Lilly USA, LLC
$389
Takeda Pharmaceuticals U.S.A., Inc.
$348
Merck Sharp & Dohme Corporation
$303
Pharmacyclics LLC, An AbbVie Company
$280
Gilead Sciences, Inc.
$242
Kite Pharma, Inc.
$241
EISAI INC.
$223
Alexion Pharmaceuticals, Inc.
$219
Clovis Oncology, Inc.
$214
Regeneron Healthcare Solutions, Inc.
$212
Boehringer Ingelheim Pharmaceuticals, Inc.
$184
EMD Serono, Inc.
$180
ARRAY BIOPHARMA INC
$164
JAZZ PHARMACEUTICALS INC.
$153
Bayer Healthcare Pharmaceuticals Inc.
$147
Bayer HealthCare Pharmaceuticals Inc.
$145
BeiGene USA, Inc.
$116
TAIHO ONCOLOGY, INC.
$110
Agios Pharmaceuticals, Inc.
$109
PharmaEssentia USA Corporation
$101
SERVIER PHARMACEUTICALS LLC
$87
Octapharma USA, Inc.
$83
G1 Therapeutics, Inc.
$82
Pharmacosmos Therapeutics Inc.
$80
Myriad Genetic Laboratories, Inc.
$76
Mirati Therapeutics, Inc.
$74
Janssen Pharmaceuticals, Inc
$73
Teva Pharmaceuticals USA, Inc.
$73
GlaxoSmithKline, LLC.
$71
Seattle Genetics, Inc.
$69
SOBI, INC
$67
Exelixis Inc.
$66
Spectrum Pharmaceuticals Inc.
$65
AVEO Pharmaceuticals, Inc.
$63
Janssen Scientific Affairs, LLC
$62
ADC Therapeutics America, Inc.
$59
Taiho Oncology, Inc.
$58
TESARO, Inc.
$54
Pharmacyclics LLC, an AbbVie Company
$53
Stemline Therapeutics Inc.
$53
Rigel Pharmaceuticals, Inc.
$53
Kub Technologies Inc.
$52
Foundation Medicine, Inc.
$50
Lexicon Pharmaceuticals, Inc.
$48
Puma Biotechnology, Inc.
$47
CTI BioPharma Corp.
$46
Heron Therapeutics, Inc.
$45
Acrotech Biopharma Inc.
$44
TerSera Therapeutics LLC
$43
MEDIVATION FIELD SOLUTIONS LLC
$41
Servier Pharmaceuticals LLC
$39
Jazz Pharmaceuticals Inc.
$36
Array BioPharma Inc.
$35
Genmab U.S., Inc.
$33
CSL Behring
$32
AbbVie Inc.
$27
Sobi, Inc
$27
ABBVIE INC.
$25
ImmunoGen, Inc.
$25
Aurobindo Pharma USA, Inc.
$24
SANOFI-AVENTIS U.S. LLC
$24
Tolmar, Inc.
$23
AMAG Pharmaceuticals, Inc.
$22
MorphoSys, US Inc.
$22
Otsuka America Pharmaceutical, Inc.
$18
PUMA BIOTECHNOLOGY, INC.
$18
Aveo Pharmaceuticals, Inc.
$16
Karyopharm Therapeutics Inc.
$15
Kyowa Kirin, Inc.
$14
Secura Bio, Inc.
$14
Verastem, Inc.
$13
EUSA Pharma (US) LLC
$13
R-Pharm US LLC
$13
Global Blood Therapeutics, Inc.
$12
SECURA BIO, INC.
$11
Top 3 companies account for 26.4% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABLIVI · CALQUENCE · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Elahere · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · Itovebi · Ixempra · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kcentra · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · Mozart · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PYRUKYND · Padcev · Perjeta · Polivy · Pomalyst · Prolia · Quzyttir · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SOLIRIS · SPRYCEL · SUTENT · Stivarga · Sustol · Sylvant · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $5 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
7
Per 100K population
1.8
County median income
$69,956
Nearest hospital
VILLAGES REGIONAL HOSPITAL, THE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rohatgi is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rohatgi experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Rohatgi performed 129,030 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rohatgi receive payments from pharmaceutical companies?
Yes. Dr. Rohatgi received a total of $22,243 from 91 companies across 982 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rohatgi's costs compare to other medical oncologys in The Villages?
Dr. Rohatgi's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rohatgi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in The Villages
Browse medical oncologys in The Villages ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Dova Pharmaceuticals Payments to Doctors
See all physicians who received payments from Dova Pharmaceuticals.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology